Review



dlbcl disease specific programme (dsp)tm database  (Adelphi Technology Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Adelphi Technology Inc dlbcl disease specific programme (dsp)tm database
    Demographics and clinical characteristics of patients with <t> DLBCL. </t>
    Dlbcl Disease Specific Programme (Dsp)tm Database, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dlbcl+disease+specific+programme+%28dsp%29tm+database/pmc11228594-261-7-6?v=Adelphi+Technology+Inc
    Average 90 stars, based on 1 article reviews
    dlbcl disease specific programme (dsp)tm database - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey"

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    Journal: Frontiers in Oncology

    doi: 10.3389/fonc.2024.1402992

    Demographics and clinical characteristics of patients with DLBCL.
    Figure Legend Snippet: Demographics and clinical characteristics of patients with DLBCL.

    Techniques Used:

    Bivariate analysis comparing EORTC QLQ-C30 scores for patients with DLBCL vs NHL reference values* † .
    Figure Legend Snippet: Bivariate analysis comparing EORTC QLQ-C30 scores for patients with DLBCL vs NHL reference values* † .

    Techniques Used:

    Disease burden of patients with DLBCL, by country: bivariate analysis.
    Figure Legend Snippet: Disease burden of patients with DLBCL, by country: bivariate analysis.

    Techniques Used: Activity Assay

    Disease burden of patients with DLBCL, by line of therapy: bivariate analysis.
    Figure Legend Snippet: Disease burden of patients with DLBCL, by line of therapy: bivariate analysis.

    Techniques Used: Comparison, Activity Assay

    Utility/functioning factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).
    Figure Legend Snippet: Utility/functioning factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).

    Techniques Used:

    Symptom factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).
    Figure Legend Snippet: Symptom factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).

    Techniques Used: Activity Assay

    Symptom burden of patients with DLBCL, by line of therapy.
    Figure Legend Snippet: Symptom burden of patients with DLBCL, by line of therapy.

    Techniques Used:

    Overall physician- and patient-reported symptoms experienced by patients with DLBCL.
    Figure Legend Snippet: Overall physician- and patient-reported symptoms experienced by patients with DLBCL.

    Techniques Used:

    Adverse events experienced by patients with DLBCL, by line of therapy.
    Figure Legend Snippet: Adverse events experienced by patients with DLBCL, by line of therapy.

    Techniques Used:



    Similar Products

    dlbcl disease specific programme (dsp)tm database  (Adelphi Technology Inc)
    90
    Adelphi Technology Inc dlbcl disease specific programme (dsp)tm database
    Demographics and clinical characteristics of patients with <t> DLBCL. </t>
    Dlbcl Disease Specific Programme (Dsp)tm Database, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dlbcl+disease+specific+programme+%28dsp%29tm+database/pmc11228594-261-7-6?v=Adelphi+Technology+Inc
    Average 90 stars, based on 1 article reviews
    dlbcl disease specific programme (dsp)tm database - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Demographics and clinical characteristics of patients with DLBCL.

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Demographics and clinical characteristics of patients with DLBCL.

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques:

    Bivariate analysis comparing EORTC QLQ-C30 scores for patients with DLBCL vs NHL reference values* † .

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Bivariate analysis comparing EORTC QLQ-C30 scores for patients with DLBCL vs NHL reference values* † .

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques:

    Disease burden of patients with DLBCL, by country: bivariate analysis.

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Disease burden of patients with DLBCL, by country: bivariate analysis.

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques: Activity Assay

    Disease burden of patients with DLBCL, by line of therapy: bivariate analysis.

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Disease burden of patients with DLBCL, by line of therapy: bivariate analysis.

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques: Comparison, Activity Assay

    Utility/functioning factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Utility/functioning factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques:

    Symptom factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Symptom factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques: Activity Assay

    Symptom burden of patients with DLBCL, by line of therapy.

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Symptom burden of patients with DLBCL, by line of therapy.

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques:

    Overall physician- and patient-reported symptoms experienced by patients with DLBCL.

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Overall physician- and patient-reported symptoms experienced by patients with DLBCL.

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques:

    Adverse events experienced by patients with DLBCL, by line of therapy.

    Journal: Frontiers in Oncology

    Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

    doi: 10.3389/fonc.2024.1402992

    Figure Lengend Snippet: Adverse events experienced by patients with DLBCL, by line of therapy.

    Article Snippet: Real-world data was drawn from the Adelphi DLBCL Disease Specific Programme (DSP)TM database, a multinational, cross-sectional survey with elements of retrospective data analysis of physicians and their adult patients conducted in the US and five European countries (France, Germany, Italy, Spain, and the UK), conducted between January 2021 and May 2021.

    Techniques: